1-4 of 4
Mercedes E. Gorre
Close
Sort by
Journal Articles

Array CGH Analysis of Chronic Lymphocytic Leukemia Reveals Frequent Cryptic Monoallelic and Biallelic Deletions of Chromosome 22q11.

William D. McClain, Shelly R. Gunn, Aswani R. Bolla, Lynn L. Barron, Mercedes E. Gorre, David W. Bahler, Clemens H. M. Mellink, Marinus H. J. van Oers, Michael J. Keating, Alessandra Ferrajoli, Kevin R. Coombes, Lynne V Abruzzo, MD, PhD, Ryan S. Robetorye
Journal: Blood
Blood (2008) 112 (11): 1050.
https://doi.org/10.1182/blood.V112.11.1050.1050
Published: 2008
Journal Articles

Altered Oncogenic Fitness of Imatinib- and Dasatinib-Resistant BCR-ABL Mutants Is Due to Differential Intrinsic Kinase Activity and Signaling Pathway Selection Defined by Phosphoproteome Profiling.

Brian J. Skaggs, PhD, Michael R. Burgess, PhD, Mercedes E. Gorre, PhD, Thomas G. Graeber, PhD, Charles L. Sawyers, MD
Journal: Blood
Blood (2005) 106 (11): 692.
https://doi.org/10.1182/blood.V106.11.692.692
Published: 2005
Journal Articles

Imatinib-Resistant BCR-ABL Mutations Alter Oncogenic Potency, Kinase Activity and Substrate Selection.

Mercedes E. Gorre, Ph.D., Brian J. Skaggs, Ph.D., Charles L. Sawyers, M.D.
Journal: Blood
Blood (2004) 104 (11): 556.
https://doi.org/10.1182/blood.V104.11.556.556
Published: 2004
Journal Articles

BCR-ABL point mutants isolated from patients with imatinib mesylate–resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90

Brief Report
Mercedes E. Gorre, Katharine Ellwood-Yen, Gabriela Chiosis, Neal Rosen, Charles L. Sawyers
Journal: Blood
Blood (2002) 100 (8): 3041–3044.
https://doi.org/10.1182/blood-2002-05-1361
Published: 2002